Page last updated: 2024-08-24

xemilofiban and Thrombosis

xemilofiban has been researched along with Thrombosis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, CS; Cines, DB1
Broschat, K; Haas, NF; Keller, BT; King, LW; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Szalony, JA; Taite, BB; Zablocki, JA1
Badimon, JJ; Badimon, L; Baron, DA; Chesebro, JH; Feigen, LP; Fuster, V; Meyer, B1
Anders, RJ; Broderick, TM; Ferguson, JJ; Hantsbarger, G; Higby, NA; Kereiakes, DJ; Kleiman, N; Martin, LH; McDonald, S; Runyon, JP1
Feigen, LP; Frederick, LG; King, LW; Nicholson, NS; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB1
Davis, CJ; Lowry, DR; McKenzie, ME; Nair, GV; Serebruany, VL1

Reviews

3 review(s) available for xemilofiban and Thrombosis

ArticleYear
Platelet glycoprotein IIb/IIIa inhibitors and thrombocytopenia: possible link between platelet activation, autoimmunity and thrombosis.
    Thrombosis and haemostasis, 2002, Volume: 88, Issue:6

    Topics: Abciximab; Alanine; Antibodies, Monoclonal; Autoimmunity; Benzamidines; Humans; Immunoglobulin Fab Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Pyrrolidines; Thrombocytopenia; Thrombosis

2002
Xemilofiban: SC 54684A, xemlofiban.
    Drugs in R&D, 2003, Volume: 4, Issue:6

    Topics: Angina Pectoris; Animals; Benzamidines; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Thrombosis

2003
Aspirin in patients with coronary artery disease: is it simply irresistible?
    Journal of thrombosis and thrombolysis, 2001, Volume: 11, Issue:2

    Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Diabetes Complications; Dipyridamole; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Thromboxane-A Synthase; Ticlopidine; Vasodilator Agents

2001

Trials

1 trial(s) available for xemilofiban and Thrombosis

ArticleYear
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment.
    Circulation, 1997, Aug-19, Volume: 96, Issue:4

    Topics: Abciximab; Administration, Oral; Aged; Antibodies, Monoclonal; Aspirin; Benzamidines; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Single-Blind Method; Stents; Thrombosis; Ticlopidine

1997

Other Studies

3 other study(ies) available for xemilofiban and Thrombosis

ArticleYear
SC-54684A: an orally active inhibitor of platelet aggregation.
    Circulation, 1995, Jan-15, Volume: 91, Issue:2

    Topics: Administration, Oral; Animals; Benzamides; Benzamidines; Biological Availability; Carbon Radioisotopes; Dogs; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Sensitivity and Specificity; Thrombosis

1995
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist.
    European journal of clinical investigation, 1997, Volume: 27, Issue:7

    Topics: Administration, Oral; Animals; Benzamidines; Blood Flow Velocity; Carotid Arteries; Carotid Artery Injuries; Dogs; Microscopy, Electron, Scanning; Perfusion; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis

1997
Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin.
    Circulation, 1998, Aug-25, Volume: 98, Issue:8

    Topics: Administration, Oral; Animals; Arterial Occlusive Diseases; Aspirin; Benzamidines; Binding Sites; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Electric Stimulation; Female; Male; Platelet Aggregation Inhibitors; Templates, Genetic; Thrombosis

1998